Surmodics cuts workforce by 13% after FDA declines to approve drug-coated balloon
[ad_1] Surmodics cuts workforce by 13% after FDA declines to approve drug-coated balloon [ad_2] Source link
[ad_1] Surmodics cuts workforce by 13% after FDA declines to approve drug-coated balloon [ad_2] Source link
[ad_1] Getaround (NYSE:GETR) will streamline operations and reduce costs to achieve a leaner path to profitability. These changes also include a workforce reduction, effective immediately, that impacts ~10% of current staff. The restructuring plan also includes significant reductions to other operating expenses, including reducing the company’s contract workforce, and outside professional services. This could take down … Read more